Question 1

What is NP/PA marketing for pharma?

Accepted Answer

NP/PA marketing for pharma is the valuation, targeting, engagement and measurement of nurse practitioners and physician associates as prescribers for a pharmaceutical or biotechnology brand. SharePath values each clinician at NPI level, finds the ones a brand plan is missing, reaches them through the brand's channels or its own, and measures prescription change.

Question 2

What is Prescriber Valuation Systems?

Accepted Answer

Prescriber Valuation Systems is SharePath's method for establishing what an individual prescriber is worth to a brand. It corrects for three common distortions in commercial data: inaccurate specialty labeling, prescription misattribution between clinicians in the same practice, and unrealized prescribing potential.

Question 3

Does SharePath replace our agency, data provider or NP/PA vendor?

Accepted Answer

No. SharePath is data-agnostic and channel-agnostic. The media agency still buys the media, sales operations still owns the call plan, and the agency of record still builds the campaign. SharePath makes sure the allocation reflects the valuation.

Question 4

How does SharePath reach nurse practitioners and physician associates?

Accepted Answer

Through a brand's own field, agency and media partners, or through Health-Scripts — SharePath's network of more than 650,000 verified clinicians — using peer-signed email (Rounds), peer-presented video (Reels), in-office briefings (Curbsides) and speaker programs (Table Talks).

What is your NP/PA opportunity worth?

Prescriber Valuation Systems™

Clinical Sharing Community

Four ways in.

Rounds™

Reels™

Curbsides™

Table Talks™

Independent by design.

We work across your ecosystem.

We stay in our lane.

NP/PA was where we started.

Leadership Team.